United States Pharmaceuticals

Api Acquisition Sub Inc (AVRX)

Track

Ticker: AVRX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Carter Kenneth C President and CEO Executive Director
Transaction date
Purchase
Price
367.38
Quantity 17,459 -22.7%
Value US$4,301,633
Carter Kenneth C President and CEO Executive Director
Transaction date
Purchase
Price
74.10
Quantity 96,659 -38.2%
Value US$501,251
Carter Kenneth C President and CEO Executive Director
Transaction date
Purchase
Price
75.59
Quantity 25,452 -18.7%
Value US$2,544,978
Carter Kenneth C President and CEO Executive Director
Transaction date
Purchase
Price
2.54
Quantity 100 +0.5%
Value US$254
Carter Kenneth C President and CEO Executive Director
Transaction date
Purchase
Price
2.49
Quantity 100 +0.5%
Value US$249
Carter Kenneth C President and CEO Executive Director
Transaction date
Purchase
Price
2.49
Quantity 500 +2.4%
Value US$1,244
Carter Kenneth C President and CEO Executive Director
Transaction date
Purchase
Price
2.48
Quantity 632 +3.1%
Value US$1,570
Carter Kenneth C President and CEO Executive Director
Transaction date
Purchase
Price
2.46
Quantity 100 +0.5%
Value US$246
Carter Kenneth C President and CEO Executive Director
Transaction date
Purchase
Price
2.65
Quantity 1,400 +7.4%
Value US$3,710
Carter Kenneth C President and CEO Executive Director
Transaction date
Sale
Price
2.64
Quantity 200 -0.9%
Value US$528
Carter Kenneth C President and CEO Executive Director
Transaction date
Sale
Price
2.63
Quantity 400 -1.8%
Value US$1,052
Carter Kenneth C President and CEO Executive Director
Transaction date
Sale
Price
2.58
Quantity 200 -0.9%
Value US$516
Carter Kenneth C President and CEO Executive Director
Transaction date
Sale
Price
2.53
Quantity 200 -0.9%
Value US$506
Carter Kenneth C President and CEO Executive Director
Transaction date
Sale
Price
2.50
Quantity 300 -1.3%
Value US$750
Carter Kenneth C President and CEO Executive Director
Transaction date
Sale
Price
2.45
Quantity 732 -3.1%
Value US$1,793
Carter Kenneth C President and CEO Executive Director
Transaction date
Purchase
Price
2.99
Quantity 3,000 +14.4%
Value US$8,970
Hamilton J Michael Chief Medical Officer Officer
Transaction date
Purchase
Price
3.09
Quantity 2,500 +1250.0%
Value US$7,725
Carter Kenneth C President and CEO Executive Director
Transaction date
Purchase
Price
3.26
Quantity 900 +3.8%
Value US$2,934
Carter Kenneth C President and CEO Executive Director
Transaction date
Purchase
Price
3.27
Quantity 100 +0.4%
Value US$327
Carter Kenneth C President and CEO Executive Director
Transaction date
Purchase
Price
3.28
Quantity 1,000 +4.4%
Value US$3,280
EuclidSR Biotechnology Partners, L.P. Non-Executive Director
Transaction date
Purchase
Price
10.50
Quantity 203,900 +inf%
Value US$2,140,950
Beneden Patrick Van Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.50
Quantity 27,210 +17.6%
Value US$285,705
Beneden Patrick Van Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.50
Quantity 154,190 +inf%
Value US$1,618,995
ROYSTON IVOR Non-Executive Director
Transaction date
Purchase
Price
10.50
Quantity 10,628 +8.5%
Value US$111,594
ROYSTON IVOR Non-Executive Director
Transaction date
Purchase
Price
10.50
Quantity 125,372 +inf%
Value US$1,316,406
OXFORD BIOSCIENCE PARTNERS III LP Large shareholder
Transaction date
Purchase
Price
10.50
Quantity 1,717 +27.5%
Value US$18,028
OXFORD BIOSCIENCE PARTNERS III LP Large shareholder
Transaction date
Purchase
Price
10.50
Quantity 13,795 +27.5%
Value US$144,848
OXFORD BIOSCIENCE PARTNERS III LP Large shareholder
Transaction date
Purchase
Price
10.50
Quantity 20,693 +27.5%
Value US$217,276
OXFORD BIOSCIENCE PARTNERS III LP Large shareholder
Transaction date
Purchase
Price
10.50
Quantity 145,195 +27.5%
Value US$1,524,548
GIMV NV Large shareholder
Transaction date
Purchase
Price
10.50
Quantity 27,210 +17.6%
Value US$285,705
GIMV NV Large shareholder
Transaction date
Purchase
Price
10.50
Quantity 154,190 +inf%
Value US$1,618,995
Whitaker Raymond J Non-Executive Director
Transaction date
Purchase
Price
10.50
Quantity 101,950 +100.0%
Value US$1,070,475
Whitaker Raymond J Non-Executive Director
Transaction date
Purchase
Price
10.50
Quantity 101,950 +inf%
Value US$1,070,475
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2008-01-23 2008-01-23 B Purchase Carter Kenneth C

President and CEO

Executive Director
17,459 -22.7%
367.38
US$4,301,633 		17,459 -22.7% 367.38 US$4,301,633
2008-01-23 2008-01-23 B Purchase Carter Kenneth C

President and CEO

Executive Director
96,659 -38.2%
74.10
US$501,251 		96,659 -38.2% 74.10 US$501,251
2008-01-23 2008-01-23 B Purchase Carter Kenneth C

President and CEO

Executive Director
25,452 -18.7%
75.59
US$2,544,978 		25,452 -18.7% 75.59 US$2,544,978
2008-01-23 2008-01-23 B Purchase Carter Kenneth C

President and CEO

Executive Director
100 +0.5%
2.54
US$254 		100 +0.5% 2.54 US$254
2008-01-23 2008-01-23 B Purchase Carter Kenneth C

President and CEO

Executive Director
100 +0.5%
2.49
US$249 		100 +0.5% 2.49 US$249
2008-01-23 2008-01-23 B Purchase Carter Kenneth C

President and CEO

Executive Director
500 +2.4%
2.49
US$1,244 		500 +2.4% 2.49 US$1,244
2008-01-23 2008-01-23 B Purchase Carter Kenneth C

President and CEO

Executive Director
632 +3.1%
2.48
US$1,570 		632 +3.1% 2.48 US$1,570
2008-01-23 2008-01-23 B Purchase Carter Kenneth C

President and CEO

Executive Director
100 +0.5%
2.46
US$246 		100 +0.5% 2.46 US$246
2008-01-23 2008-01-23 B Purchase Carter Kenneth C

President and CEO

Executive Director
1,400 +7.4%
2.65
US$3,710 		1,400 +7.4% 2.65 US$3,710
2008-01-23 2008-01-17 S Sale Carter Kenneth C

President and CEO

Executive Director
200 -0.9%
2.64
US$528 		200 -0.9% 2.64 US$528
2008-01-23 2008-01-17 S Sale Carter Kenneth C

President and CEO

Executive Director
400 -1.8%
2.63
US$1,052 		400 -1.8% 2.63 US$1,052
2008-01-23 2008-01-17 S Sale Carter Kenneth C

President and CEO

Executive Director
200 -0.9%
2.58
US$516 		200 -0.9% 2.58 US$516
2008-01-23 2008-01-17 S Sale Carter Kenneth C

President and CEO

Executive Director
200 -0.9%
2.53
US$506 		200 -0.9% 2.53 US$506
2008-01-23 2008-01-17 S Sale Carter Kenneth C

President and CEO

Executive Director
300 -1.3%
2.50
US$750 		300 -1.3% 2.50 US$750
2008-01-23 2008-01-17 S Sale Carter Kenneth C

President and CEO

Executive Director
732 -3.1%
2.45
US$1,793 		732 -3.1% 2.45 US$1,793
2006-08-31 2006-08-30 B Purchase Carter Kenneth C

President and CEO

Executive Director
3,000 +14.4%
2.99
US$8,970 		3,000 +14.4% 2.99 US$8,970
2006-08-30 2006-08-28 B Purchase Hamilton J Michael

Chief Medical Officer

Officer
2,500 +1250.0%
3.09
US$7,725 		2,500 +1250.0% 3.09 US$7,725
2006-08-24 2006-08-22 B Purchase Carter Kenneth C

President and CEO

Executive Director
900 +3.8%
3.26
US$2,934 		900 +3.8% 3.26 US$2,934
2006-08-24 2006-08-22 B Purchase Carter Kenneth C

President and CEO

Executive Director
100 +0.4%
3.27
US$327 		100 +0.4% 3.27 US$327
2006-08-24 2006-08-22 B Purchase Carter Kenneth C

President and CEO

Executive Director
1,000 +4.4%
3.28
US$3,280 		1,000 +4.4% 3.28 US$3,280
2005-10-18 2005-10-04 B Purchase EuclidSR Biotechnology Partners, L.P. Non-Executive Director
203,900 +inf%
10.50
US$2,140,950 		203,900 +inf% 10.50 US$2,140,950
2005-10-06 2005-10-04 B Purchase Beneden Patrick Van Non-Executive Director Large shareholder
27,210 +17.6%
10.50
US$285,705 		27,210 +17.6% 10.50 US$285,705
2005-10-06 2005-10-04 B Purchase Beneden Patrick Van Non-Executive Director Large shareholder
154,190 +inf%
10.50
US$1,618,995 		154,190 +inf% 10.50 US$1,618,995
2005-10-06 2005-10-04 B Purchase ROYSTON IVOR Non-Executive Director
10,628 +8.5%
10.50
US$111,594 		10,628 +8.5% 10.50 US$111,594
2005-10-06 2005-10-04 B Purchase ROYSTON IVOR Non-Executive Director
125,372 +inf%
10.50
US$1,316,406 		125,372 +inf% 10.50 US$1,316,406
2005-10-06 2005-10-04 B Purchase OXFORD BIOSCIENCE PARTNERS III LP Large shareholder
1,717 +27.5%
10.50
US$18,028 		1,717 +27.5% 10.50 US$18,028
2005-10-06 2005-10-04 B Purchase OXFORD BIOSCIENCE PARTNERS III LP Large shareholder
13,795 +27.5%
10.50
US$144,848 		13,795 +27.5% 10.50 US$144,848
2005-10-06 2005-10-04 B Purchase OXFORD BIOSCIENCE PARTNERS III LP Large shareholder
20,693 +27.5%
10.50
US$217,276 		20,693 +27.5% 10.50 US$217,276
2005-10-06 2005-10-04 B Purchase OXFORD BIOSCIENCE PARTNERS III LP Large shareholder
145,195 +27.5%
10.50
US$1,524,548 		145,195 +27.5% 10.50 US$1,524,548
2005-10-06 2005-10-04 B Purchase GIMV NV Large shareholder
27,210 +17.6%
10.50
US$285,705 		27,210 +17.6% 10.50 US$285,705
2005-10-06 2005-10-04 B Purchase GIMV NV Large shareholder
154,190 +inf%
10.50
US$1,618,995 		154,190 +inf% 10.50 US$1,618,995
2005-10-06 2005-10-04 B Purchase Whitaker Raymond J Non-Executive Director
101,950 +100.0%
10.50
US$1,070,475 		101,950 +100.0% 10.50 US$1,070,475
2005-10-06 2005-10-04 B Purchase Whitaker Raymond J Non-Executive Director
101,950 +inf%
10.50
US$1,070,475 		101,950 +inf% 10.50 US$1,070,475
Explore more

More insider trading research around Api Acquisition Sub Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America